Esperion Therapeutics Inc

Research Esperion Therapeutics Inc (ESPR) on Bullrun: market cap USD 810.91M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerESPR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 810.91M
• Financial periodFY2025
• RevenueUSD 403.14M
• Revenue growth21.3%
• Net income-USD 22.68M
• Free cash flow-USD 13.09M

Valuation Snapshot

latest market cap is USD 810.91M.

About Esperion Therapeutics Inc

Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Frequently asked questions

What is Esperion Therapeutics Inc's market cap?

Esperion Therapeutics Inc's market capitalization is USD 810.91M.

What does Esperion Therapeutics Inc do?

Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.